Yes I increased my position in CTTC over the years. How can the press not pick up a double-blind study out of an institution like Johns Hopkins. That is headline stuff in the opioid crisis world we live in. I expect the results to be a multiple better than the current pharma treatments in the market today. With NO side effects. That is a story!
By-the-way check out the most recent doctor (a neurologist) who has purchased a device:
Selena W. Ellis, MD 3000 Colby Street, Suite 101 Berkeley, CA 94705 Tel: 510.644.2282
Look at her CV
President of The San Francisco Neurological Society
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.